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Abstract
Background:  Sodium channel (NaCh) expressions change following nerve and inflammatory
lesions and this change may contribute to the activation of pain pathways. In a previous study we
found a dramatic increase in the size and density of NaCh accumulations, and a remodeling of
NaChs at intact and altered myelinated sites at a location just proximal to a combined partial
axotomy and chromic suture lesion of the rat infraorbital nerve (ION) with the use of an antibody
that identifies all NaCh isoforms. Here we evaluate the contribution of the major nodal NaCh
isoform, Nav1.6, to this remodeling of NaChs following the same lesion. Sections of the ION from
normal and ION lesioned subjects were double-stained with antibodies against Nav1.6 and caspr
(contactin-associated protein; a paranodal protein to identify nodes of Ranvier) and then z-series
of optically sectioned images were captured with a confocal microscope. ImageJ (NIH) software
was used to quantify the average size and density of Nav1.6 accumulations, while additional single
fiber analyses measured the axial length of the nodal gap, and the immunofluorescence intensity of
Nav1.6 in nodes and of caspr in the paranodal region.
Results: The findings showed a significant increase in the average size and density of Nav1.6
accumulations in lesioned IONs when compared to normal IONs. The results of the single fiber
analyses in caspr-identified typical nodes showed an increased axial length of the nodal gap, an
increased immunofluorescence intensity of nodal Nav1.6 and a decreased immunofluorescence
intensity of paranodal caspr in lesioned IONs when compared to normal IONs. In the lesioned
IONs, Nav1.6 accumulations were also seen in association with altered caspr-relationships, such as
heminodes.
Conclusion: The results of the present study identify Nav1.6 as one isoform involved in the
augmentation and remodeling of NaChs at nodal sites following a combined partial axotomy and
chromic suture ION lesion. The augmentation of Nav1.6 may result from an alteration in axon-
Schwann cell signaling mechanisms as suggested by changes in caspr expression. The changes
identified in this study suggest that the participation of Nav1.6 should be considered when
examining changes in the excitability of myelinated axons in neuropathic pain models.
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Background
Voltage-gated sodium channels (NaChs) are recognized as
a diverse group that consist of at least nine different sub-
types or isoforms [1]. The activation of NaChs is a key
event leading to action potential generation and impulse
propagation [2]. These isoforms are differentially distrib-
uted throughout the nervous system and show important
changes in expression after inflammatory and axotomy
insults and some of these changes may contribute to the
development and maintenance of pain states [3]. Much
attention has been placed on the evaluation of changes in
the expression of specific isoforms after lesions and espe-
cially of those that are preferentially expressed in the
peripheral nervous system [4]. Much less is known about
changes in expression after peripheral injury of isoforms
that are more widely expressed in both the peripheral and
central nervous systems, such as Nav1.6.
The Nav1.6 isoform is strongly expressed by sensory neu-
rons [5], located in unmyelinated fibers [6] and also rep-
resents the isoform located at nodes of Ranvier [5,7]. The
node of Ranvier contains a high density of NaChs whose
activation is necessary for saltatory conduction [8] and
thus represents a key region influencing the excitability of
myelinated fibers. Changes in the density or distribution
of NaChs at the node of Ranvier may contribute to
changes in excitability that follow experimental nerve
insults or in disease states. Even though Nav1.6 plays a key
role in the propagation of action potentials throughout
the nervous system, studies that have evaluated changes in
its expression in pain states are limited [9].
We are studying the role of altered NaCh expression in
trigeminal pain states and have used a combined partial
axotomy and chromic suture lesion of the rat infraorbital
nerve (ION) that produces a behavior characterized by
increased sensitivity to mechanical stimuli as a model sys-
tem where we can quantify changes in expression within
single fibers [10]. Through the use of this model and
methodology, we have described significant remodeling
and augmentation of NaCh immunofluorescence within
intact and presumably demyelinating nodes of Ranvier
with the use of a "pan-specific" antibody that recognizes a
conserved sequence seen in the alpha subunit of all verte-
brate NaCh isoforms [11,12]. In this study we use the
same lesion and evaluate the contribution of the Nav1.6
isoform to the remodeling of NaChs that was identified
with the pan-specific antibody used in the earlier study.
Results
Behavioral response to monofilament stimulation
Monofilament stimulation of the vibrissa pad two weeks
after the ION lesion showed less force was needed to pro-
duce a threshold behavioral response (defined as head
withdrawal, bite filament, attack filament, prolonged
directed grooming, and/or scratching of the stimulated
vibrissa pad) on the side of the lesion when compared to
that seen in normal control subjects. The four normal con-
trol subjects showed either a lack of threshold response or
threshold response only with the maximum 26 gram force
stimulus, while the experimental subjects individually
showed threshold responses after 1, 2, 6 and 15 gram
force stimulations.
Qualitative observations of Nav1.6 and caspr staining 
patterns and relationships in normal vs. lesioned IONs
Examination of the Nav1.6 and caspr-staining patterns
and relationships with the confocal microscope revealed a
dramatic difference in the extent and intensity of immun-
ofluorescence of both Nav1.6 and caspr between normal
and lesioned IONs (Figs. 1 and 2). Typical nodes of Ran-
vier were identified as the gap seen between the paranodal
staining of caspr with the Nav1.6 staining at nodes in nor-
mal IONs assuming a prominent disc-like appearance
(Figs. 1A and 2A). The caspr staining was typically intense
and selective within the paranodal region and associated
with sharp demarcation borders. Most of the large Nav1.6
accumulations with bright staining intensity were associ-
Nav1.6 and caspr staining Figure 1
Nav1.6 and caspr staining. A and B. Confocal micro-
graphs from average-intensity z-projections (45 slices in A; 
47 slices in B) demonstrate Nav1.6 (red) and caspr (green) 
staining relationships seen within the normal (A) and lesioned 
(B) ION. A. The normal ION shows bright Nav1.6 staining 
(arrowhead) at nodes of Ranvier that are identified as the gap 
seen between the paranodal staining of caspr. The caspr 
staining is intense within the paranodal region and prominent 
Nav1.6 staining is generally restricted to the narrow area at 
the node. B. The lesioned ION, at a location just proximal to 
the chromic suture, shows a change in the Nav1.6 and caspr 
staining relationships that were seen in A. These changes 
include a loss in the overall organization and the immunofluo-
rescence intensity of caspr staining within the paranodal 
region (arrowheads) and an increased size and intensity of 
Nav1.6 within accumulations (large arrows). Alterations in 
the normal Nav1.6 and caspr staining relationships include 
Nav1.6 accumulations that show an association with caspr on 
one side (heminodes; small arrow). Both images were col-
lected with the same laser settings. Scale bars = 10 µm.
Normal
Na 1.6 v      + caspr Na 1.6 v      + caspr
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ated with prominent caspr staining seen in the paranodal
regions. Weak staining of caspr was also seen along some
nerve fibers.
In contrast, the typical association of intense Nav1.6 at the
node bordered on both sides by bright caspr staining in
the paranodal area was altered in lesioned IONs (compare
Fig. 1A to 1B and Fig. 2A to 2B). In general, both the inten-
sity and the area occupied by Nav1.6 immunofluorescence
increased at nodes, while the paranodal staining of caspr
appeared attenuated. The Nav1.6 accumulations in
lesioned tissue appeared larger, brighter and more ovoid
rather than the disc-like appearance seen in normal IONs.
The caspr staining associated with these "typical" nodes
also appeared less intense. The common relationship of
caspr with Nav1.6 was also altered in some accumulations
and included the presence of "heminodes" where caspr
staining was located on only one side of a contiguous
Nav1.6 accumulation and "split nodes" where two distinct
NaCh accumulations were separated by a gap in the same
fiber and with each accumulation flanked on one side by
caspr (Fig. 2B). Finally, the total number of Nav1.6 accu-
mulations appeared to be significantly increased in the
lesioned tissue (i.e. density appeared to be much higher).
In contrast to the dense Nav1.6 staining seen at nodes,
selective labeling of fibers that lacked an association with
caspr, and that most likely represent unmyelinated fibers,
was absent in the IONs of both control and lesioned sub-
jects.
Since the apparent density, size (including the nodal gap
axial length) and intensity of Nav1.6 accumulations, and
the intensity of caspr staining in the paranodal region of
typical nodes appeared so different in lesioned IONs
when compared to normal IONs, these observations were
evaluated further using quantitative techniques.
Quantitative evaluation of the density and size of Nav1.6 
accumulations in normal vs. lesioned IONs
Quantitative evaluation determined that the density (Fig.
3A) and size (Fig. 3B) of Nav1.6 accumulations were both
significantly greater in the lesioned IONs when compared
to normal IONs. The density analysis (as determined by
the number of Nav1.6 accumulations/mm2) calculated a
density of 397.6 +/- 51.6 (SEM) accumulations/mm2 in
lesioned IONs and 191.2 +/- 17.4 (SEM) accumulations/
mm2 in normal IONs (p < 0.01 significance level; Fig. 3A).
The average size (in pixels) of Nav1.6 accumulations was
53.6 +/- 1.4 (SEM) in lesioned IONs and 36.6 +/- 0.86
(SEM) in normal IONs (p < 0.01 significance level; Fig.
3B).
Results of quantitative analyses performed in normal (N) and  lesioned (L) infraorbital nerves Figure 3
Results of quantitative analyses performed in normal 
(N) and lesioned (L) infraorbital nerves. A and B. The 
density (A) and average pixel size (B) of Nav1.6 accumula-
tions (with a size of ≥ 15 pixels) was significantly greater in 
lesioned IONs than seen in normal IONs. C. The average 
immunofluorescence intensity (0–65,535 range) of pixels 
with Nav1.6 staining located in caspr-identified typical nodes 
was significantly greater in lesioned IONs when compared to 
normal IONs. D. The average axial length (in pixels) of the 
nodal gap within caspr-identified typical nodal accumulations 
was significantly greater in lesioned IONs when compared to 
normal IONs. E. The average immunofluorescence intensity 
(0–65,535 range) of pixels with caspr staining located within 
the paranodal regions of caspr-identified typical nodes was 
significantly greater in normal IONs when compared to 
lesioned IONs.
Nav1.6 and caspr staining Figure 2
Nav1.6 and caspr staining. A and B. Confocal migrog-
raphs of Nav1.6 (red) and caspr (green) staining relationships 
seen within individual fibers in the normal (A) and lesioned 
(B) ION. A. Individual fibers within the normal ION show 
bright Nav1.6 staining (arrowhead) at nodes of Ranvier that 
are identified as the gap seen between the dense paranodal 
staining of caspr (arrow). B. Individual fibers within the 
lesioned ION show alterations in the Nav1.6 and caspr stain-
ing relationships that include "heminodes" (small arrow-
heads) and "split nodes" that vary in the distance seen 
between the Nav1.6 accumulations (small and large arrows). 
Some large Nav1.6 accumulations are flanked on both sides 
by reduced caspr staining (large arrowheads), while other 
nodes appear more normal (asterick). Scale bars = 5 µm.BMC Neuroscience 2007, 8:56 http://www.biomedcentral.com/1471-2202/8/56
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Quantitative evaluation of Nav1.6 and caspr 
immunofluorescence staining intensities and nodal gap 
axial length within single caspr-identified typical nodes in 
normal vs. lesioned IONs
The average intensity of pixels with Nav1.6 immunofluo-
rescence located within typical nodes was significantly
greater (p < 0.01) in lesioned IONs when compared to
normal IONs (5571.8 +/- 294.1 (SEM) vs. 3529.6 +/- 90.3
(SEM); Fig. 3C). In addition, the analysis of typical node-
salso showed that the average nodal gap axial length as
measured by the number of pixels in the caspr-demar-
cated gap that is occupied by Nav1.6, was significantly
greater (p < 0.01) in lesioned IONs than in normal IONs
(7.72 +/- 0.29 (SEM) vs. 3.95 +/- 0.13 (SEM); Fig. 3D).
Thus Nav1.6 nodal clusters appear to have significantly
broadened in lesioned IONs. In contrast, the evaluation
of the average intensity of pixels with caspr immunofluo-
rescence within the paranodal region of typical nodes
showed that this intensity was significantly less (p < 0.01)
in the lesioned IONs when compared to normal IONs
(1614.7 +/- 48.2 (SEM) vs. 2565.4 +/- 102.1 (SEM); Fig.
3E).
Discussion
In a previous study we described striking changes in NaCh
expression in a location just proximal to a combined par-
tial axotomy and chromic suture lesion of the ION [10].
The present investigation specifically identifies the
involvement of the Nav1.6 isoform in the augmentation
and remodeling of NaChs at intact and presumptive
demyelinating sites and in the increased density of NaCh
accumulations that were previously identified with the
use of the pan-specific NaCh antibody in this nerve injury
model. Most studies that have evaluated the role of altered
NaCh expression in peripheral pain states (inflammatory
and/or neuropathic) have focused on the role of the
Nav1.7, 1.8 and 1.9 isoforms that are preferentially
expressed in the peripheral nervous system and seen in a
subset of nociceptors [13-15] and on the re-expression of
Nav1.3 after injury [16]. Many of these have evaluated
changes in protein and gene expressions at the cell body
level, while fewer have evaluated changes in single fibers
at the site of nerve injury. Although Nav1.6 has been iden-
tified as the major isoform located at nodes of Ranvier in
both the peripheral and central nervous systems [5,7], few
studies have examined changes in its localization or
expression in disease and injury states in the peripheral
nervous system. One study did evaluate Nav1.6 expression
in an experimental painful diabetic neuropathy rat model
and found increased mRNA and protein levels in sensory
neurons thus implicating the involvement of this isoform
in the generation of altered neuronal activity in this pain
condition [9].
Two primary questions that arise from the present obser-
vations concern; 1) the mechanisms underlying such
changes in sodium channel expression, and 2) the possi-
ble role of such changes in the establishment and mainte-
nance of a chronic hyperalgesic state. With respect to the
first question, Bennett and Xie introduced the use of chro-
mic suture ligation of the sciatic nerve to produce a rat
model of neuropathic pain [17] and this lesion was later
adapted to the rat ION [18]. Chromic suture nerve lesions
result in behavior that is suggestive of neuropathic pain
and this behavior may be due in part to chemicals present
in the chromic suture [19]. However, chromic suture pro-
duces a potent inflammatory response [20], and this
localized inflammatory response may contribute to the
development of a demyelinating lesion.
A number of previous studies have shown that disruption
of myelin results in profound changes in NaCh expression
in axons [10,11,21-26]. Paranodal and segmental demy-
elination are both associated with a widening of the nodal
gap [27] and an augmentation of NaChs can occur within
this gap [28], thus accounting for similar observations
seen in the present study. This widened nodal gap may
result from a disruption of axoglial signaling mechanisms
that are critical to the localization of ion channels into the
nodal and paranodal regions of the axolemma [29-31].
The reduction of caspr staining seen in the paranodal
region within the lesioned IONs has also been seen in
axons within demyelinating lesions in patients with mul-
tiple sclerosis [32], and most likely reflects altered signal-
ing mechanisms occurring in early stages of paranodal
demyelination. Furthermore, NaCh clusters have been
reported to form spontaneously in chronically demyeli-
nated axonal segments [22-26], and this could account for
the increased number of Nav1.6 clusters observed in the
present study, particularly those associated with altered
caspr relationships such as heminodes. Heminodes are
normally seen during development [33] and after experi-
mentally-induced demyelination with lysolecithin
[11,27,34,35]. Although it seems likely that most of the
changes that we observed after the use of the combined
partial axotomy/chromic suture lesion result from altera-
tions in myelination secondary to the use of the chromic
suture, our methods did not allow a differentiation of
NaCh remodeling in fibers affected by axotomy and chro-
mic suture to those affected by chromic suture alone and
so attributes from the axotomy are possible.
The Nav1.6 isoform may also be involved in the pathogen-
esis of demyelination. Studies done in humans and exper-
imental animal models for multiple sclerosis have shown
Nav1.6 expression in activated glia within the central nerv-
ous system [36]. In addition, it has been reported that
Nav1.6 colocalizes with the Na+/Ca+ exchanger in demy-
elinated axons with the suggestion that this colocalizationBMC Neuroscience 2007, 8:56 http://www.biomedcentral.com/1471-2202/8/56
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may trigger axon injury [21]. Together, these previous
findings and our present findings suggest an important
role for Nav1.6 in both peripheral and central demyelinat-
ing conditions.
The role of such pathological changes in NaCh distribu-
tions to neuropathic pain mechanisms is less certain. One
popular hypothesis is that such localized increases in
channel expression results in increased action potential
generation near the injury site, thus contributing to the
activation of pain pathways [37]. Furthermore, it has been
proposed that increased NaCh clusters in demyelinated
axons may contribute to repetitive firing and thus act like
pacemaker zones that are normally located within axonal
endings [38]. Even so, the changes seen here may result in
decreased excitability and this possibility identifies the
need for additional studies that evaluate changes in NaCh
expression with alterations in neuronal excitability.
Since we limited our quantitative evaluation of Nav1.6 to
those located in large accumulations, such as those found
at nodes of Ranvier in myelinated fibers, we most likely
did not evaluate possible changes in expression within
unmyelinated fibers. Even though Nav1.6 has been
described in unmyelinated axons (6), the selective labe-
ling of small fibers that lacked paranodal caspr staining
was absent in the IONs of both control and lesioned sub-
jects. This difference could be related to the use of differ-
ent antibodies. Thus, the possible contribution of the
Nav1.6 accumulations within the myelinated fibers evalu-
ated in the present study to neuropathic pain mechanisms
would likely arise through stimulation of the normal A-
delta or A-beta pathways. Naturally, possible changes in
the expression of Nav1.6 in unmyelinated fibers would be
important to evaluate in the future since altered activity
after inflammatory and axotomy lesions most likely
involves contributions from both myelinated and unmy-
elinated axons.
The development of isoform-specific inhibitors would be
useful to further understand the role of each isoform to
the development of a complex acute and chronic pain
state. Concurrent changes in multiple isoforms are cer-
tainly possible and these changes may be site specific at
the subcellular level, so that some have greater influence
within the axon, soma or central projections of sensory
neurons. Nonetheless, evidence is rapidly accruing that
sodium channel expression is highly plastic in various
forms of inflammatory and neuropathic pain conditions,
begging the question of how such changes might be causal
to pain mechanisms.
Conclusion
Our findings identify the involvement of Nav1.6 in the
augmentation and remodeling of NaChs at nodal sites
within single fibers located just proximal to the site of a
combined partial axotomy and chromic suture lesion to
the ION. The augmentation of Nav1.6 may result from an
alteration in axon-Schwann cell signaling mechanisms as
suggested by changes in caspr expression. The changes
identified in this study suggest that the activation of
Nav1.6 may be important when examining changes in
excitability of myelinated axons in various models of
inflammatory and neuropathic pain.
Methods
Animals and surgical procedures
This study was approved by the University of Colorado
Health Sciences Center Animal Care and Use Committee.
Four young adult female Sprague-Dawley rats (200–225
grams) were used as experimental subjects, while four
were used as normal control subjects in this study. The
experimental subjects were anesthetized with an intraperi-
toneal injection of pentobarbital (10 mgs per subject) or
chloral hydrate (80 mgs per subject) and once pain-free
the left ION was exposed just distal to the infraorbital
foramen by way of a midline incision over the snout. The
connective tissue overlying the ION was carefully
removed until the multiple fascicles that comprise the
nerve were visualized. The ION was released from the
deeper tissues by passing a blunt probe under the nerve.
Two 4-0 chromic gut sutures (Ethicon Inc., Somerville,
New Jersey) were then placed around the ION just distal
to the foramen, and the nerve was partially constricted as
the sutures were tightened. The lateral half of the ligated
nerve fascicles were then transected just distal to the
sutures, while the medial half of the nerve fascicles were
left intact and thus spared. The superficial incision was
closed with Dexon 4-0 suture. Experimental subjects were
given acetaminophen in drinking water (2 mg/ml) two
days prior to surgery that continued through the fourth
day after surgery. Two of the normal control subjects and
two of the lesioned subjects were used in a previous study
[10].
Behavioral testing
Experimental and normal control subjects were tested one
day before sacrifice for threshold-withdrawal response to
graded stimulation of the vibrissae pads with Semmes-
Weinstein monofilaments ("Touch-Test Sensory Evalua-
tor": North Coast Medical Inc., Morgan Hill, CA) as previ-
ously described [10]. Monofilaments with 1, 2, 4, 6, 8, 10,
15 and 26 gram forces were sequentially applied until a
threshold response was obtained (see Results).
Tissue processing and staining
Following a two week survival period the experimental
subjects and normal control subjects were deeply anesthe-
tized with an intraperitoneal injection of pentobarbital
(25 mgs) and then transcardially perfused with 100 mls ofBMC Neuroscience 2007, 8:56 http://www.biomedcentral.com/1471-2202/8/56
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0.9% saline in H2O followed by 250 mls of fixative con-
sisting of 4% paraformaldehyde in 0.1 M phosphate
buffer (PB) at pH 7.4. The ION was exposed and removed
extending from its origin at the maxillary/ophthalmic
division root to its termination in the vibrissa pad and
then post-fixed in the same fixative for 20 minutes at
room temperature. The sutures were left in place around
the nerves of experimental subjects for orientation pur-
poses. Fixed nerves were rinsed in 0.1 M PB, followed by
a rinse in 0.1 M PB with 15% sucrose at room temperature
for one hour. The IONs were then placed in 0.1 M PB with
30% sucrose overnight on a shaker at 4°C.
Separate IONs from different subjects were placed side-
by-side, embedded in mounting medium (Neg-50; Rich-
ard-Allan Scientific, Kalamazoo, MI) and sectioned in the
longitudinal plane at 40 µm with the use of a cryostat. Sec-
tions were placed onto Superfrost Plus slides (Fisher Sci-
entific, Pittsburgh, PA), allowed to dry and stored in a -
20°C freezer. The specimens were removed from the
freezer prior to staining and all subsequent steps
described below were performed at room temperature.
The specimens were rinsed three times in 0.1 M phos-
phate buffered saline (PBS) for 10 minutes in each rinse.
Non-specific binding was decreased by the incubation of
the tissue with 2% bovine gamma-globulin (Sigma, St.
Louis, MO), 4% normal goat serum (Sigma) and 0.3% Tri-
ton X-100 (Fisher Scientific) in 0.1 M PBS for 90 minutes
as a blocking solution. The blocking solution was
removed and the tissue was incubated in primary antibod-
ies diluted in blocking solution and placed overnight in a
humidifier.
An antibody specific to the nodal NaCh isoform Nav1.6
[7] was used at a 1:100 concentration, while a caspr (par-
anodin/contactin-associated protein) monoclonal anti-
body [39] was used at a 1:500 concentration. The caspr
antibody was used to identify nodes of Ranvier that are
seen as gaps between the paranodal staining of caspr. The
next day the tissue was rinsed in 0.1 M PBS followed by
incubation in secondary antibodies diluted to a 1:100
concentration in blocking solution for 90 minutes in a
humidifier while protected from the light. An Alexa Fluor
568-conjugated anti-rabbit IgG secondary antibody (red
fluorophore; Molecular Probes, Eugene, OR) was used to
visualize Nav1.6, while an Alexa Fluor 488-conjugated
anti-mouse IgG secondary antibody (green fluorophore;
Molecular Probes) was used to visualize caspr. Tissues
were rinsed in 0.1 M PBS, then water, allowed to dry, cov-
erslipped with Vectashield (Vector Labs, Burlingame, CA)
and stored at 4°C. Control tissue specimens were proc-
essed as above except the undiluted Nav1.6 antibody was
preincubated with peptide antigen (200:1 peptide to anti-
body molar concentration ratio) for a minimum of four
hours before the peptide-blocked antibody was diluted
and applied to the tissue. Tissue specimens were evaluated
and digital immunofluorescence images acquired with a
Nikon PCM-2000 laser scanning confocal microscope and
SimplePCI software, v4.0 (Compix Inc., Cranberry Town-
ship, PA). The evaluation of control tissue specimens
showed they lacked Nav1.6 staining. The Nav1.6 and caspr
staining in experimental and control subjects was quanti-
tatively evaluated as described below. Original images
were formatted with Adobe Photoshop CS and Corel
Photo-Paint 12 for illustration purposes.
Image acquisition
Longitudinal sections of the IONs that had been double-
stained with Nav1.6 and caspr antibodies as described
above were examined with the confocal microscope. A "z-
series" was obtained through each section, at 0.8 µm
steps, using a 40X/N.A. 1.30 oil immersion objective. The
gain levels used to quantify both Nav1.6 and caspr stain-
ings were set by examining tissue from each subject with
the confocal microscope to determine the specimen with
the brightest pixels. This tissue was then used to deter-
mine the laser gain levels where the brightest pixel was
just below saturation. These gain levels were then applied
for the acquisition of all images. The tissues were mini-
mally evaluated prior to capture of the z-series to avoid
photo-bleaching. Z-series images were first obtained for
Nav1.6-alone staining followed by an additional z-series
of the corresponding caspr-alone staining. Similar regions
of the nerve in normal and lesioned IONs were selected
for imaging and corresponded to the region approxi-
mately 0.2 mm proximal to the placement of the most
proximal chromic suture in the experimental subjects.
Each image was saved as a 16 bit file with a 1024 pixels2
resolution, with each square pixel = 0.3 µm in dimension
and representing an area of 0.09 µm2.
Quantification of Nav1.6 accumulation density and size
Using NIH ImageJ software [40], matching z-series
(Nav1.6-alone, caspr-alone, or Nav1.6 combined with
caspr) were opened simultaneously with each series dis-
played on its own monitor in a multi-screen array. The
combined images allowed characterization of Nav1.6 and
caspr staining relationships. Quantitative analysis was
performed with ImageJ on every 8th slice (6.4 µm separa-
tion) within the Nav1.6-alone z-series (beginning with the
third slice) to determine the average size and density of
Nav1.6 accumulations within a defined area of the ION.
At least four and up to six different slices/images within
each Nav1.6 z-series were used for this purpose. This dis-
tance was used to avoid multiple counts of the same accu-
mulations. The corresponding caspr-alone slice was used
to visualize the nerve area of the slice with the aid of the
auto button in the "brightness and contrast" menu and
this area was outlined with the "freehand selections" tool
and added to the "ROI Manager". This was done toBMC Neuroscience 2007, 8:56 http://www.biomedcentral.com/1471-2202/8/56
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exclude areas devoid of fibers. The "Measure" function in
the "ROI Manager" was used to determine the total area of
the ROI so accumulation density could be determined.
The corresponding Nav1.6-alone slice was then opened
and the image thresholded to a value where low-levels of
background staining were mostly eliminated, without the
removal of pixels from Nav1.6 accumulations. This part of
the quantification process was performed twice, and the
different threshold values were compared with an
unpaired Student's t-test. No significant difference was
found between these different threshold values. The fiber
area ROI was then applied to the thresholded Nav1.6
image and the "Analyze Particles" function under the
"Analyze" menu was employed to determine the total
count and average size of accumulations that were ≥ 15
pixels in size within the ROI.
Quantification of Nav1.6 and caspr immunofluorescence 
in single fibers
The average staining intensity of nodal Nav1.6, the average
staining intensity of paranodal caspr, and the axial length
of the nodal gap of randomly selected typical nodes were
determined in the IONs of the normal and lesioned sub-
jects. This evaluation was limited to typical nodes since
the altered types that are commonly seen in lesioned sub-
jects (i.e. heminodes) were rare in normal subjects. Typi-
cal nodes were identified and defined by the presence of a
dense Nav1.6 accumulation flanked on both sides by the
paranodal staining of caspr as seen in the Nav1.6 com-
bined with caspr z-series. The same typical node was then
identified in the Nav1.6-alone z-series that was viewed
with ImageJ as an average intensity z-projection. The
"auto" function in the "brightness and contrast" menu
was utilized to better visualize the edges of the pixels of
interest within the Nav1.6 accumulations. This step
allowed an objective method of distinguishing pixels
within the Nav1.6 accumulation that were included in the
evaluation, without altering intensity values. The Nav1.6
accumulation was traced with the "freehand" tool and a
histogram was generated to collect the number of pixels,
average intensity, and standard deviation values for that
accumulation. Fifteen individual typical nodes per z-series
in normal subjects and 9–15 typical nodes in lesioned
subjects were evaluated. The average intensity of paran-
odal caspr staining was determined from an average inten-
sity z-projection of the caspr-alone z-series and included
measurements of caspr staining on both sides of 7–17 typ-
ical nodes that were randomly selected from each z-series
(53 nodes were each evaluated in lesioned IONs and nor-
mal IONs). The area of caspr staining on each side of the
node where intensity was measured was identified as a
"region of interest" or "ROI" in a merged maximum-
intensity z-projection of the matching Nav1.6 combined
with caspr z-series. This "ROI" was then added to the "ROI
Manager" function found under the "Analyze" menu and
applied to the caspr-alone average-intensity z-projection.
A histogram was then obtained of this "ROI" that
recorded the number of pixels, average intensity, and
standard deviation of intensity staining within the area
containing caspr staining. The nodal gap axial length (the
gap between caspr) was measured at high magnification
in these same nodes with the use of the "straight line selec-
tions" tool in the merged maximum-intensity z-projec-
tion. Since the number of individual slices within a z-
series varied from 39–49, the Nav1.6 and caspr pixel value
intensities obtained from each average-intensity z-projec-
tion were normalized to the z-projection with the greatest
number of slices. All evaluations were done by one inves-
tigator to minimize variability in assessment.
Statistical analysis
Statistical analysis to determine significance used the
unpaired Student t-test while error bars on all graphs rep-
resent the standard error of the mean.
Abbreviations
sodium channels (NaChs); infraorbital nerve (ION);
region of interest (ROI); standard error of the mean
(SEM).
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